quantisnow
FeedTopReportsPricing
⌘K
Live feed
18:06:26·155d
INSIDERFiling
Surmodics Inc. logo

Chief Financial Officer Arens Timothy J. returned 67,299 shares to the company, closing all direct ownership in the company (SEC Form 4)

SRDX· Surmodics Inc.
Health Care
Original source

Companies

  • SRDX
    Surmodics Inc.
    Health Care

Recent analyst ratings

  • Nov 14UpdateBarrington Research-
  • Mar 7UpdateLake Street$43.00
  • Jun 13UpdateNeedham$36.00
  • Feb 13UpdateNeedham-
  • Feb 4UpdateNeedham$58.00
  • Nov 10UpdateNeedham$70.00

Related

  • SEC143d
    SEC Form 15-12G filed by Surmodics Inc.
  • SEC154d
    SEC Form EFFECT filed by Surmodics Inc.
  • SEC154d
    Amendment: SEC Form SCHEDULE 13D/A filed by Surmodics Inc.
  • INSIDER155d
    SVP, Medical Device Coatings Olson Charles W returned 52,278 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER155d
    VP Finance, Corp. Controller Manders John D. returned 8,155 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER155d
    Sr. VP of Legal, GC and Sec. Weber Gordon S. returned 21,040 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER155d
    SVP, Vascular Interventions Sides Teri Woodwick returned 34,703 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER155d
    Director Dantzker David returned 40,183 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022